Gleamer is a medical technology company that specializes in developing AI-powered solutions for medical imaging analysis, particularly in the field of radiology.

Gleamer

GLEAMER offers a suite of AI solutions for radiology that encapsulate medical-grade expertise. Our company wants to support imaging readers to secure diagnoses for all patients at all times while improving comfort and workflow efficiency.
Our team imagines and develops solutions booth at the level of an expert and is easy to integrate thanks to the joint work of a multi-disciplinary team encapsulating AI and radiologist experts.
GLEAMER has already been integrated into more than 650 institutions in each part of the world. 

🏅Alexander Margulis award - Scientific excellence for the BoneView clinical study 🏅
🏅 2023 Eurominnies awards - Best New Radiology Vendor🥇

Bpifrance

Kima Ventures

Elaia

XAnge

MACSF

Majycc eSanté Invest

Crista Galli Ventures

Fonds Ambition Amorçage Angels

Heal Capital

Supernova Invest

UI Investissement

GLEAMER

🚀RSNA 2023 Countdown has Begun! 

The RSNA 2023 will open its doors in just a few days, and the Gleamer team is thrilled to meet you in person. We're eager to demonstrate how our AI copilot revolutionizes radiology practices, enhances diagnostics, and optimizes workflows. 

✨ Discover Innovation at Our Booth Experience. Learn more about our four solutions, including BoneView, the CE MDR, and the FDA-approved AI solution for fracture detection across adults and pediatrics. 

🔍 Real Results, Real Impact! Hear from our satisfied users through their stories and learn about the tangible benefits they've experienced firsthand, backed by robust scientific research. 

📅 Book Your Exclusive Demo Spaces! Secure your spot to explore our transformative technology in a one-on-one session with our experts. Visit Gleamer AI Demo Reservation to reserve your time slot: https://lnkd.in/emxhB79s

Looking forward to seeing you there, 
The Gleamer Team 

 #RSNA2023 #GLEAMER #AIFORHEALTH #AI#HealthTech

🔊 We're incredibly proud to welcome Prof. Gabriel Paul Krestin to the Gleamer Board of Directors as an Independent Member! 

📈 Prof. Krestin's expertise is not just academic; his entrepreneurial journey, including founding and leading Quantib BV, positions him uniquely to guide us at Gleamer. His advisory roles, including with GE Healthcare Europe, and his leadership in organizations like the European Society of Radiology (ESR) are testament to his profound impact on the field. 

🚀 At Gleamer, we believe AI is the key to revolutionizing medical imaging, especially in the face of an aging population and increasing healthcare demands. Prof. Krestin's vision and experience will be invaluable as we continue to develop AI solutions to support radiologists and clinicians worldwide. 

✨ Join us in welcoming Prof. Krestin and celebrating this new chapter in our journey to enhance radiology through innovative AI technology. Together, we're not just imagining the future of medical imaging - we're creating it!

 #Gleamer #MedicalImaging #AI #Radiology #HealthTech #Innovation 

🔗 Learn more about our work at https://lnkd.in/e93F7Xpu

Exciting News! 🌟 

We are delighted to announce that we have been honored with the "Santé Future" (Healthcare of the Future) award by the prestigious Décideurs Magazine!

This accolade recognizes the most innovative and effective collaboration between hospitals and startups. A special thanks to CHU Rennes for the positive feedback on the impact of BoneView within their organization. Your support underscores the transformative power of our partnership and allows us to be awarded. 

Together, we're forging a new path in healthcare, combining cutting-edge technology with compassionate care to revolutionize patient outcomes. 

Stay tuned as we continue to make strides in healthcare innovation! 

🏆 If you want to read more about the trophy: https://lnkd.in/dg7kjRzb

#SantéDuFuture #InnovationHealthcare #CHURennes #BoneView #HealthTechAwards #DécideurMagazine #AIRadiology 

🏥 Calling all radiologists and clinicians: Brace yourselves for an elevated diagnostic experience with ChestView! 🫁 

This state-of-the-art technology offers an immediate and automatic second opinion on chest X-rays, ushering in a new era in diagnostic and triage approaches. With ChestView as your trusted partner, you'll benefit from rapid and precise image analysis, empowering you to make well-informed decisions for your patients. 🤝💙🔬 

Explore the remarkable capabilities of ChestView AI today. 

Visit our website to delve deeper into this groundbreaking innovation: https://lnkd.in/emxhB79s ✨ 

#ChestView #RadiologyInnovation #MedicalAdvancements #GLEAMER #DiagnosticBreakthroughs #AIinHealth

🎉 Thank you to all our incredible visitors, partners, and the phenomenal Gleamer team for making #RSNA2023 an unforgettable event! 

Your enthusiasm for our solutions has been astounding, and we're thrilled to embark on this journey together. 

Until next year, Chicago! 🌟 

⏰ Final call, #RSNA2023 attendees! 

Today marks the last chance to experience the magic at Booth 4373. 

Dive into our cutting-edge solution revolutionizing radiology practices! 🌟 

Let us demonstrate how our AI copilot takes diagnostics to new heights and streamlines workflows for enhanced efficiency. 

Swing by – it's your moment to witness the future of radiology! 🚀 

#RadiologyInnovation #AIinHealthcare"

Metric
Company Name	Gleamer
Symbol
MSH ID	AI:GLEAMER
Market	PRIVATE
Sector	Medical Devices & Equipment
Industry	Healthcare Technology
Country	FR
Stage	Series B
Employee Count	79
Website	gleamer.ai
LinkedIn	gleamer
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	5.23K
Web Traffic Growth	0.66
Valuation
Raised Capital	29.47M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

AI:GLEAMER

Gleamer

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue